Table 1.
Demographic and baseline clinical characteristics of the study subjects
| Characteristics | Calcipotriol + 5-FU (n = 54) | Vaseline + 5-FU (n = 52) | P-Value |
|---|---|---|---|
| Age, mean (SD), y | 68.0 (6.9) | 70.4 (9.5) | 0.143 |
| Range | 51–88 | 52–89 | |
| Sex, n (%) | 0.316 | ||
| Male | 44 (81) | 46 (88) | |
| Female | 10 (19) | 6 (12) | |
| Drug amount used, mean (SD), g | 15.42 (9.7) | 16.54 (9.2) | 0.547 |
| Baseline sites treated, n (%) | 0.447 | ||
| Forehead | 37 (69) | 27 (52) | |
| Temples | 18 (33) | 23 (44) | |
| Cheek | 11 (20) | 19 (37) | |
| Scalp | 25 (46) | 25 (48) | |
| Forearm | 16 (30) | 17 (33) | |
| Baseline actinic keratosis count on each site, median (IQR) | |||
| Forehead | 8 (3) | 7 (4) | 0.073 |
| Temples | 5 (1) | 6 (3) | 0.698 |
| Cheek | 9 (2.5) | 7 (3) | 0.095 |
| Scalp | 6 (2) | 6 (2) | 0.544 |
| Forearm | 8 (6) | 8 (6) | 0.929 |
Abbreviations: 5-FU, 5-fluorouracil; IQR, interquartile range.